drugset / Trial / NCT04144218
Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
Phase 4
Unknown
300 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
Juntendo University · collabMichigan State University · collabRIKEN · collabTechnical University of Munich · collabTongji Hospital · collabUniversity of California, Los Angeles · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Children with focal refractory epilepsy will be routinely included in the collection of history, blood routine, biochemistry, EEG, MRI and 18F-FDG PET to determine the location of the epileptogenic focus and to assess the severity of the disease. This international multicenter clinical trial uses a double-blind, randomized, controlled study to evaluate the safety and efficacy of LCM in clinical applications in children with epilepsy.
Timeline
- Start
- 2019-11-08
- Primary completion
- 2021-10
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | — | Oral |